Krystal Biotech, Inc.

KRYS

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001711279

SEC filings (opens in a new tab)

In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Krystal Biotech, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of KRYS: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	245	2	283	+40
Shares	28.5M	3.95M	28.3M	+3.70M (+15.0%)
Value	$5.24B	$725.0M	$5.15B	+$633.9M (+14.0%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (55)

Institutions that held Krystal Biotech, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to KRYS in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	3,993,123	$726.9M	0.02%
First Trust Advisors LP	39,411	$7.17M	0.01%
Edgestream Partners, L.P.	32,257	$5.87M	0.26%
Renaissance Technologies LLC	14,400	$2.62M	0.00%
Twinbeech Capital LP	13,724	$2.50M	0.05%
Federated Hermes, Inc.	12,819	$2.33M	0.01%
Illinois Municipal Retirement Fund	12,641	$2.30M	0.03%
State of Tennessee, Treasury Department	11,562	$2.10M	0.01%
Summit Trail Advisors, LLC	10,401	$1.89M	0.05%
Intech Investment Management LLC	7,270	$1.32M	0.01%
Headlands Technologies LLC	6,834	$1.24M	0.14%
Pathstone Holdings, LLC	5,047	$918.7K	0.00%
Scientech Research LLC	3,925	$714.5K	0.14%
Main Management ETF Advisors, LLC	3,880	$706.0K	0.03%
Credit Agricole S A	3,336	$607.3K	0.00%
Engineers Gate Manager LP	3,261	$593.6K	0.01%
Everence Capital Management Inc	3,060	$557.0K	0.04%
Shaker Investments LLC	2,920	$531.5K	0.22%
Options Solutions, LLC	2,699	$491.3K	0.24%
Advantage Alpha Capital Partners LP	2,289	$416.7K	0.09%
Acadian Asset Management LLC	2,280	$415.0K	0.00%
Brevan Howard Capital Management LP	2,094	$381.2K	0.02%
Argent Trust Co	1,899	$345.7K	0.01%
Blueshift Asset Management, LLC	1,823	$331.8K	0.08%
Boothbay Fund Management, LLC	1,703	$310.0K	0.01%
Cerity Partners LLC	1,542	$280.7K	0.00%
HSBC Holdings PLC	1,531	$277.8K	0.00%
Wolverine Trading, LLC	1,538	$272.4K	0.01%
O'Shaughnessy Asset Management, LLC	1,425	$255.9K	0.00%
Veriti Management LLC	1,385	$252.1K	0.01%
Transcend Wealth Collective, LLC	1,382	$251.6K	0.02%
Oppenheimer Asset Management Inc.	1,289	$234.6K	0.00%
Sound View Wealth Advisors Group, LLC	1,200	$218.4K	0.02%
LPL Financial LLC	1,147	$208.8K	0.00%
Hilltop Holdings Inc.	1,146	$208.6K	0.01%
American Century Companies Inc	1,099	$200.1K	0.00%
Mount Yale Investment Advisors, LLC	1,027	$186.9K	0.02%
Danske Bank A/S	300	$54.6K	0.00%
Values First Advisors, Inc.	292	$53.1K	0.03%
LMR Partners LLP	232	$42.2K	0.00%
Bryn Mawr Trust Co	218	$39.7K	0.00%
ADAR1 Capital Management, LLC	100	$18.2K	0.00%
Walleye Capital LLC	97	$17.7K	0.00%
Citadel Advisors LLC	96	$17.5K	0.00%
Clearstead Advisors, LLC	39	$7.10K	0.00%
Sterling Capital Management LLC	25	$4.55K	0.00%
Rakuten Securities, Inc.	16	$2.91K	0.00%
Annis Gardner Whiting Capital Advisors, LLC	10	$1.82K	0.00%
Sound Income Strategies, LLC	10	$1.82K	0.00%
Wolff Wiese Magana LLC	8	$1.46K	0.00%
SRS Capital Advisors, Inc.	6	$1.09K	0.00%
Capital Performance Advisors LLP	4	$728	0.00%
Mendota Financial Group, LLC	2	$365	0.00%
Bokf, NA	2	$352	0.00%
Avion Wealth	3	$0	0.00%

Sold out (15)

Institutions that held Krystal Biotech, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of KRYS in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Integral Health Asset Management, LLC	85,000	$15.6M
Balyasny Asset Management LLC	59,810	$11.0M
Hillsdale Investment Management Inc.	21,000	$3.86M
ExodusPoint Capital Management, LP	14,892	$2.73M
Ghost Tree Capital, LLC	8,500	$1.56M
Pearl River Capital, LLC	5,027	$923.2K
Caxton Associates LP	3,621	$665.0K
Capula Management Ltd	2,404	$441.5K
Algert Global LLC	1,853	$340.3K
Pacer Advisors, Inc.	238	$43.7K
Ashton Thomas Private Wealth, LLC	38	$6.98K
Itau Unibanco Holding S.A.	14	$2.57K
Innealta Capital, LLC	14	$2.57K
Abich Financial Wealth Management LLC	14	$2.57K
CIBC Private Wealth Group, LLC	4	$765

Not filed for Q3 2024 yet (2)

Institutions that held Krystal Biotech, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KRYS in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	3,947,845	$725.0M
Institutional & Family Asset Management, LLC	4	$735